Literature DB >> 9696499

Mast cell, myofibroblast and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers.

H Akiyoshi1, T Terada.   

Abstract

BACKGROUND/AIMS: Extracellular matrices in liver fibrosis are known to be produced by myofibroblasts that are transformed from fat-storing cells. The development of the fibrotic process is thought to be mediated by various fibrogenic mediators. Recently, the involvement of mast cells and cholinergic neurotransmitters in fibrogenesis has been suggested. We have studied the distribution of these cells and cholinergic nerve fibers in normal rat livers and 6-week carbon tetrachloride-induced rat cirrhotic livers.
METHODS: Mast cells and myofibroblasts were identified by immunohistochemistry for mast cell tryptase (AA1) and alpha-smooth muscle actin. Cholinergic nerve fibers and terminals were localized using the acetylcholinesterase neurohistochemistry method for light and transmission electron microscopy.
RESULTS: In normal rat livers, a few nerve terminals were connected with fibroblasts near the vascular walls in the portal tracts. In contrast, in cirrhotic rat livers, numerous acetylcholinesterase-positive nerve fibers were observed in the fibrous septa, forming a network. Ultrastructurally, the nerve terminals were observed in close contact with mast cells and myofibroblasts in fibrous septa, forming characteristic mast cell/myofibroblast/nerve terminal complexes. In cirrhotic nodules, nerve terminals were situated in close contact with myofibroblasts in the periseptal sinusoids. These axon terminals contained numerous small clear vesicles, and acetylcholinesterase-positive products were noted in the space of the synaptic membranes.
CONCLUSIONS: Our findings demonstrate that mast cell/ myofibroblast/cholinergic nerve terminal complexes may play a role in the development of liver fibrosis, probably because of the production of extracellular matrix components by myofibroblasts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696499     DOI: 10.1016/s0168-8278(98)80185-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  16 in total

1.  Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents.

Authors:  Lindsey L Kennedy; Laura A Hargrove; Allyson B Graf; Taylor C Francis; Kyle M Hodges; Quy P Nguyen; Yoshi Ueno; John F Greene; Fanyin Meng; Victoria D Huynh; Heather L Francis
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

2.  Synaptophysin: A novel marker for human and rat hepatic stellate cells.

Authors:  D Cassiman; J van Pelt; R De Vos; F Van Lommel; V Desmet; S H Yap; T Roskams
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice.

Authors:  Hannah Jones; Laura Hargrove; Lindsey Kennedy; Fanyin Meng; Allyson Graf-Eaton; Jennifer Owens; Gianfranco Alpini; Christopher Johnson; Francesca Bernuzzi; Jennifer Demieville; Sharon DeMorrow; Pietro Invernizzi; Heather Francis
Journal:  Hepatology       Date:  2016-07-30       Impact factor: 17.425

4.  Protective effect of quercetin on liver damage induced by biliary obstruction in rats.

Authors:  Mehmet Kanter
Journal:  J Mol Histol       Date:  2010-10-20       Impact factor: 2.611

5.  Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice.

Authors:  Laura Hargrove; Lindsey Kennedy; Jennifer Demieville; Hannah Jones; Fanyin Meng; Sharon DeMorrow; Walker Karstens; Taronish Madeka; John Greene; Heather Francis
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

6.  Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis.

Authors:  Yoshiyuki Takahara; Mitsuo Takahashi; Hiroki Wagatsuma; Fumihiko Yokoya; Qing-Wei Zhang; Mutsuyo Yamaguchi; Hiroyuki Aburatani; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

7.  Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis.

Authors:  Da-Hee Jeong; Gi-Ppeum Lee; Won-Il Jeong; Sun-Hee Do; Hai-Jie Yang; Dong-Wei Yuan; Ho-Yong Park; Kyu-Jong Kim; Kyu-Shik Jeong
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

8.  Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers.

Authors:  Maya Vladova Gulubova
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 9.  Hepatic Nervous System in Development, Regeneration, and Disease.

Authors:  Bess M Miller; Isaac M Oderberg; Wolfram Goessling
Journal:  Hepatology       Date:  2021-08-15       Impact factor: 17.425

10.  Macrophages, myofibroblasts and mast cells in a rat liver infected with Capillaria hepatica.

Authors:  Won-Il Jeong; Sun-Hee Do; Il-Hwa Hong; Ae-Ri Ji; Jin-Kyu Park; Mi-Ran Ki; Seung-Chun Park; Kyu-Shik Jeong
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.